EMA IDMP Roadmap: Updates, Requirements and Impact on Industry (Session 1 of 2)

By the end of 2024, EMA released updated IDMP guidance and the PMS implementation guide, following key milestones including the go-live of PMS. Closely connected to SPOR, XEVMPD, SIAMED, and various EMA platforms, the IDMP project demands active collaboration between industry and NCAs.

In this session, we cover:

  • Key updates to PMS and their impact on industry
  • EMA guidance updates and compliance prerequisites
  • Use of the Union List of Critical Medicines and the ESMP platform
  • PMS as a central source of product data
  • Revised IDMP timelines and required industry actions
  • MAH obligations and practical implementation challenges

The EMA IDMP project remains active, with increasing complexity. Achieving compliance requires data readiness and process optimisation to meet evolving deadlines and implementation phases.

Simply fill out the form and scroll down to access the webinar recording.

Come join more than 450 Life Sciences companies around the world being powered by Ennov

The Impact of Ennov RIM at Foghorn Therapeutics

Efficient regulatory information management can be complex. Your software shouldn’t be. 

DISCOVER MORE CASE STUDIES

Aguettant Case Study

“It’s really nice to work with a software provider that shows a great deal of innovative spirit, has great ambition and is proactive. Above all, I really appreciate Ennov placing particular emphasis on the customer’s user experience.”

Cyrille Jeune,
Regulatory Affairs Systems Manager

Read The Case Study

Septodont Case Study

“With more than 1500 MAAs in 150 countries, we face a real productivity challenge. With Ennov, we have been able to issue 400 dossier in just 18 months. For the first time, our users are experiencing tremendous time savings when locating documents.”

Aurélie Becquet,
Regulatory Affairs

Read The Case Study